Skip to main content
SpringerLink
Log in

Prognostic value of exercise tolerance test for predicting cardiovascular disease in asymptomatic individuals with heterozygous familiar hypercholesterolemia

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Heterozygous familiar hypercholesterolemia (hFH) is an autosomal dominant inherited dyslipidemia, associated with premature cardiovascular disease (CVD). Aim of the study was to define prognostic factors for cardiovascular events (CVE) in asymptomatic individuals with hFH. All participants with recent diagnosis of hFH were recruited from the outpatient lipid clinic from 1987 to 2016, without any previous clinical evidence of CVD. A detailed clinical evaluation and laboratory investigation was obtained. Exercise tolerance test (ETT) was performed until maximum exercise capacity was achieved, without evidence of ischemia. Primary endpoint of the study was the first CVE. Four hundred fifty one participants were followed up for 10 ± 8 years, with 68 recorded cases of CVD (15%). Cumulative incidence of CVD was 15%, 24% and 32% for the 3 decades, respectively. In univariate analysis, male gender (p = 0.016), progression of age (p < 0.001), menopause (p = 0.030), waist–hip ratio (p = 0.043) and increased levels of Lp(α) (p = 0.014) were significantly associated with increased CVD incidence; whereas, exercise capacity (p = 0.025), low variation of heart rate (HR) during all stages of ETT compared to resting state (p = 0.020), maximum systolic (p = 0.014) and diastolic (p < 0.001) blood pressure were inversely associated with CVD. In multi-adjusted analysis, male gender (p < 0.001), duration of ETT (p = 0.023), estimated HR (p = 0.029), variation of HR during ETT compared to resting state (p < 0.05) and maximum diastolic pressure (p = 0.044) were significantly associated with CVD. Parameters of ETT in asymptomatic individuals with hFH, without any evidence of ischemia, may predict CVD in these high-risk patients after decades of observation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Soutar AK (1992) Familial hypercholesterolaemia and LDL receptor mutations. J Intern Med 231:633–641

    Article  CAS  Google Scholar 

  2. Goldstein JL, Brown MS (1979) The LDL receptor locus and the genetics of familial hypercholesterolemia. Annu Rev Genet 13:259–289

    Article  CAS  Google Scholar 

  3. Khachadurian AK (1964) The inheritance of essential familial hypercholesterolemia. Am J Med 37:402–407

    Article  CAS  Google Scholar 

  4. Davignon J, Genest J (1998) Genetics of lipoprotein disorders. Endocrinol Metab Clin N Am 27:521–550

    Article  CAS  Google Scholar 

  5. Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Boren J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybjaerg-Hansen A, European Atherosclerosis Society Consensus Panel (2013) Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 34:3478–3490

    Article  CAS  Google Scholar 

  6. Hill JS, Hayden MR, Frohlich J, Pritchard PH (1991) Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familiar hypercholesterolemia. Arterioscler Thromb 11:290–297

    Article  CAS  Google Scholar 

  7. Villa G, Wong B, Kutikova L, Ray KK, Mata P, Bruckert E (2017) Prediction of cardiovascular risk in patients with familiar hypercholesterolemia. Eur Heart J Qual Care Clin Outcomes 3:274–280

    Article  Google Scholar 

  8. Koivisto UM, Hamalainen L, Taskinen MR, Kettunen K, Kontula K (1993) Prevalence of familiar hypercholesterolemia among young north Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction. J Lipid Res 34:269–277

    CAS  PubMed  Google Scholar 

  9. Perez de Isla L, Alonso R, Mata N, Saltijeral A, Muniz O, Rubio-Marin P, Diaz-Diaz JL, Fuentes F, de Andres R, Zambon D, Galiana J, Piedecausa M, Aquado R, Mosquera D, Vidal JI, Ruiz E, Manjon L, Mauri M, Padro T, Miramontes JP, Mata P, SAFEHEART Investigators (2016) Coronary heart disease, peripheral arterial disease and stroke in familiar hypercholesterolemia: Insights from the SAFEHEART Registry (Spanish Familiar Hypercholesterolemia Cohort Study). Arterioscler Thromb Vasc Biol 36:2004–2010

    Article  CAS  Google Scholar 

  10. Wong B, Kruse G, Kutikova L, Ray KK, Mata P, Bruckert E (2016) Cardiovascular disease risk associated with familiar hypercholesterolemia: a systematic review of the literature. Clin Ther 38:1696–1709

    Article  Google Scholar 

  11. Williams RR, Hunt SC, Schumacher MC, Hegele RA, Leppert MF, Ludwig EH, Hopkins PN (1993) Diagnosing heterozygous familiar hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol 72:171–176

    Article  CAS  Google Scholar 

  12. Sijbrands EJ, Westendorp RG, Paola Lombardi M, Havekes LM, Frants RR, Kastelein JJ, Smelt AH (2000) Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia. Atherosclerosis 149:421–425

    Article  CAS  Google Scholar 

  13. Real JT, Chaves FJ, Martinez-Uso I, Garcia-Garcia AB, Ascaso JF, Carmena R (2001) Importance of HDL cholesterol levels and the total/HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia. Eur Heart J 22:465–471

    Article  CAS  Google Scholar 

  14. Panagiotakos DB, Pitsavos C, Skoumas J, Chrysohoou C, Toutouza M, Stefanadis CI, Toutouzas PK (2003) Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familiar hypercholesterolaemia: a 15-year follow-up (1987–2002). Curr Med Res Opin 19:89–94

    CAS  PubMed  Google Scholar 

  15. Hausmann D, Johnson JA, Sudhir K, Mullen WL, Friedrich G, Fitzgerald PJ, Chou TM, Ports TA, Kane JP, Malloy MJ, Yock PG (1996) Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins. J Am Coll Cardiol 27:1562–1570

    Article  CAS  Google Scholar 

  16. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP, Frick MH (1992) Joint effects of serum triglycerides and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 85:37–45

    Article  CAS  Google Scholar 

  17. Scientific Steering Committee on behalf of the Simon Broome Register Group (1999) Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis 142:105–112

    Article  Google Scholar 

  18. Elisaf M, Bairaktari H, Siamopoulos KC (1996) Lp(a) levels in Greek patients with heterozygous familial hypercholesterolemia. Int J Cardiol 53:314–316

    Article  CAS  Google Scholar 

  19. Lingenhel A, Kraft HG, Kotze M, Peeters AV, Kronenberg F, Krusee R, Utermann G (1998) Concentrations of the atherogenic Lp(a) are elevated in FH. Eur J Hum Genet 6:50–60

    Article  CAS  Google Scholar 

  20. Perez de Isla L, Alonso R, Mata N, Fernandez-Perez C, Muniz O, Diaz-Diaz JL, Saltijeral A, Fuentes-Jimenez F, de Andres R, Zambon D, Piedecausa M, Cepeda JM, Mauri M, Galiana J, Brea A, Sanchez Munoz-Torrero JF, Padro T, Arqueso R, Miramontes-Gonzalez JP, Badimon L, Santos RD, Watts GF, Mata P (2017) Predicting cardiovascular events in familiar hypercholesterolemia: the SAFEHEART Registry (Spanish Familiar Hypercholesterolemia Cohort Study). Circulation 135:2133–2144

    Article  Google Scholar 

  21. Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C, Toutouzas PK (2002) Risk stratification of coronary heart disease in Greece: final results from the CARDIO2000 Epidemiological Study. Prev Med 35:548–556

    Article  Google Scholar 

  22. Pitsavos C, Chrysohoou C, Panagiotakos DB, Skoumas J, Zeimbekis A, Kokkinos P, Stefanadis C, Toutouzas PK (2003) Association of leisure-time physical activity on inflammation markers (C-reactive protein, white cell blood count, serum amyloid A and fibrinogen), in healthy subjects (from the ATTICA study). Am J Cardiol 91:368–370

    Article  CAS  Google Scholar 

  23. Hopkins PN (2002) Familial hypercholesterolemia. Curr Treat Options Cardiovasc Med 4:121–128

    Article  Google Scholar 

  24. Civeira F, Castillo S, Alonso R, Merino-Ibarra E, Cenarro A, Artied M, Martin-Fuentes P, Ros E, Pocovi M, Mata P, Spanish Familiar Hypercholesterolemia Group (2005) Tendon xanthomas in familiar hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation. Arterioscler Thromb Vasc Biol 25:1960–1965

    Article  CAS  Google Scholar 

  25. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE (2002) Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346:793–801

    Article  Google Scholar 

  26. Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT (1994) Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med 330:1549–1554

    Article  CAS  Google Scholar 

  27. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Health GW, King AC (1995) Physical activity and public health A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273:402–407

    Article  CAS  Google Scholar 

  28. Pitsavos CH, Chrysohoou C, Panagiotakos DB, Kokkinos P, Skoumas J, Papaioannou I, Michaelides AP, Singh S, Stefanadis CI (2004) Exercise capacity and heart rate recovery as predictors of coronary heart disease events, in patients with heterozygous familial hypercholesterolemia. Atherosclerosis 173:347–352

    Article  CAS  Google Scholar 

  29. de Perez Isla L, Alonso R, Muniz-Grijalvo O, Diaz-Diaz JL, Zambon D, Miramontes JP, Fuentes F, Gomez de Diego JJ, Gonzalez-Estrada A, Mata N, Saltijeral A, Barreiro M, Tomas M, de Andres R, Arqueso R, Serrano Gotarredona MP, Navarro Herrero S, Perea Palazon RJ, de Caralt TM, Suarez de Centi LA, Zhilina S, Espejo Perez S, Padro T, Mata P, SAFEHEART Investigators (2018) Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familiar hypercholesterolemia. Lessons from the SAFEHEART study. J Clin Lipidol 12:948–957

    Article  Google Scholar 

  30. Sturm AC, Knowles JW, Gidding SS, Ahmad ZS, Ahmed CD, Ballantyne CM, Baum SJ, Bourbon M, Carrie A, Cuchel M, de Ferranti SD, Defesche JC, Freiberger T, Herschberger RE, Hovingh GK, Karayan L, Kastelein JJP, Kindt I, Lane SR, Leigh SE, Linton MF, Mata P, Neal WA, Nordestgaard BG, Santos RD, Harada-Shiba M, Sijbrands EJ, Stitziel NO, Yamashita S, Wilemon KA, Ledbetter DH, Rader DJ, Convened by the Familiar Hypercholesterolemia Foundation (2018) Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel. J Am Coll Cardiol 72:662–680

    Article  Google Scholar 

  31. van Aalst-Cohen ES, Jansen AC, Tanck MW, Defesche JC, Trip MD, Lansberg PJ, Stalenhoef AF, Kastelein JJ (2006) Diagnosing familial hypercholesterolemia: the relevance of genetic testing. Eur Heart J 27:2240–2246

    Article  Google Scholar 

  32. Amor-Salamaca A, Castillo S, Gonzalez-Vioque E, Dominguez F, Quintana L, Lluis-Ganella C, Escudier JM, Ortega J, Lara-Pezzi E, Alonso-Pulpon L, Garcia-Pavia P (2017) Genetically confirmed familial hypercholesterolemia in patients with acute coronary syndrome. J Am Coll Cardiol 70:1732–1740

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Cardiology Department, “Hippokration” Hospital, School of Medicine, University of Athens, Athens, Greece

    Ioanna Papaioannou, John Skoumas, Christos H. Pitsavos & Dimitrios Tousoulis

  2. Department of Internal Medicine, Argolidos General Hospital, Athens, Greece

    Christos E. Lampropoulos

  3. Department of Nutrition-Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece

    Demosthenes B. Panagiotakos

Authors
  1. Ioanna Papaioannou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christos E. Lampropoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Demosthenes B. Panagiotakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John Skoumas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christos H. Pitsavos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dimitrios Tousoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ioanna Papaioannou.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (include name of committee + reference number) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Papaioannou, I., Lampropoulos, C.E., Panagiotakos, D.B. et al. Prognostic value of exercise tolerance test for predicting cardiovascular disease in asymptomatic individuals with heterozygous familiar hypercholesterolemia. Heart Vessels 35, 259–267 (2020). https://doi.org/10.1007/s00380-019-01482-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-019-01482-2

Keywords

Search

Navigation